Parallax Volatility Advisers, L.P. Amgen Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $40.8 Million - $44.5 Million	131,900 Added 37.38%	484,800 $156 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $29.7 Million - $36.1 Million	-112,900 Reduced 24.24%	352,900 $110 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $53.6 Million - $64.7 Million	199,300 Added 74.78%	465,800 $132 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $39.4 Million - $44.4 Million	153,900 Added 136.68%	266,500 $76.8 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $20 Million - $24.8 Million	-91,300 Reduced 44.78%	112,600 $30.3 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $4.69 Million - $5.55 Million	21,900 Added 12.03%	203,900 $45.3 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $13.5 Million - $16.4 Million	-59,700 Reduced 24.7%	182,000 $44 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $14.2 Million - $18.1 Million	-62,100 Reduced 20.44%	241,700 $63.5 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $13.1 Million - $14.7 Million	58,200 Added 23.7%	303,800 $68.5 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $8.91 Million - $9.91 Million	38,600 Added 18.65%	245,600 $59.8 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $45.4 Million - $50.2 Million	206,900 Added 206900.0%	207,000 $50.1 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $21.5 Million - $24.6 Million	-107,900 Reduced 99.91%	100 $22,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $24 Million - $26.6 Million	102,800 Added 1976.92%	108,000 $26.3 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $13.1 Million - $15.6 Million	-60,600 Reduced 92.1%	5,200 $1.2 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $14.3 Million - $15.9 Million	61,000 Added 1270.83%	65,800 $16.7 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $7.08 Million - $8.69 Million	-35,800 Reduced 88.18%	4,800 $1.13 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $52.7 Million - $69.9 Million	-289,300 Reduced 87.69%	40,600 $8.23 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $9.9 Million - $12.7 Million	52,300 Added 18.84%	329,900 $79.5 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $23.5 Million - $28.2 Million	135,200 Added 94.94%	277,600 $53.7 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2.5 Million - $2.93 Million	-15,000 Reduced 9.53%	142,400 $26.2 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $117 Million - $132 Million	-648,800 Reduced 80.48%	157,400 $29.9 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $138 Million - $161 Million	774,700 Added 2459.37%	806,200 $157 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $22 Million - $24.8 Million	-118,500 Reduced 79.0%	31,500 $6.53 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $8.47 Million - $9.9 Million	50,000 Added 50.0%	150,000 $25.6 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $16.7 Million - $19.1 Million	100,000	100,000 $18.6 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account